ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,172,814 | -6.3% | 9,603 | -20.8% | 0.01% | 0.0% |
| Q3 2022 | $1,252,000 | +417.4% | 12,124 | +366.7% | 0.01% | +600.0% |
| Q2 2022 | $242,000 | +1513.3% | 2,598 | +2261.8% | 0.00% | – |
| Q4 2021 | $15,000 | -31.8% | 110 | -20.3% | 0.00% | – |
| Q3 2021 | $22,000 | -74.1% | 138 | -78.6% | 0.00% | -100.0% |
| Q2 2021 | $85,000 | +123.7% | 646 | +122.0% | 0.00% | – |
| Q1 2021 | $38,000 | -74.1% | 291 | -67.0% | 0.00% | -100.0% |
| Q4 2020 | $147,000 | +1370.0% | 881 | +857.6% | 0.00% | – |
| Q1 2020 | $10,000 | -99.0% | 92 | -98.9% | 0.00% | -100.0% |
| Q1 2019 | $1,002,000 | +254.1% | 8,517 | +88.3% | 0.03% | +146.2% |
| Q4 2018 | $283,000 | – | 4,522 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |